GRPR and prostate cancer: In this contribution, we report on the detailed physico-chemical characterization of the resulting Pt-containing AuNP-BBN-Pt (Pt = Pt1-Pt3) nanoparticles (see Figure 1) and describe their preclinical evaluation in the prostate cancer PC3 cell line overexpressing the GRPR.